Sundeep has over 15 years of leadership experience with building teams, developing talent, and successfully growing, managing and selling businesses in healthcare marketing and technology. Prior to Medivo, Sundeep was the CEO and co-founder of Medsite, Inc. (sold to WebMD in 2006). He established Medsite as a leader in online pharmaceutical marketing and services by building an extensive online community of health care professionals, including over 400,000 US physicians. He secured financing from a range of blue chip investors, including JP Morgan Partners, Morgan Stanley, Bain, and Reuters. After the sale of Medsite to WebMD in the fall of 2006, he worked on integration, new product development, and corporate strategy at WebMD. Mr. Bhan received his BA from the Annenberg School of Communications at the University of Pennsylvania, with a concentration in business from the Wharton School of Business. He was one of the ‘Top 5 Under 35’ by the Asian Indian Chambers of Commerce, and was a 3-time finalist for the Ernst and Young “Entrepreneur of the Year” award. He is currently a Director of the Board of Terasol Energy, 2012 NYC Venture Fellow, a member of the Leadership Council of CASI at the University of Pennsylvania and serves on the Advisory Board of KNB Communications, Inc.
Dr. Bhan is a practicing Family Physician and seasoned entrepreneur serving as the EVP and Medical Director of Medivo. He is regarded as an emerging national expert in the applications of technology to healthcare and medicine, a topic on which he lectures and speaks regularly at conferences across the country. He co-founded Ozmosis, Inc., the physician’s trusted network and resource for medical knowledge. While in medical school, he served as the Medical and Technology Officer for VirtualMed, Inc. Dr. Bhan obtained his Doctor of Medicine at the University of Miami School of Medicine in 2000. From 2000 to 2003 he completed his residency with the Medical College of Virginia (MCV), serving as Chief Resident in 2003. He is board certified in Family Medicine. His passion is population health, wellness, and education. Dr. Bhan practices medicine part-time in affiliation with Inova Hospital Systems.
Dr. Sulkes has held executive positions in healthcare IT settings for over 15 years, including roles as Managing Director at Medsn, Inc., since acquired by Indegene, Managing Director at MedsiteCME, a subsidiary of Medsite, Inc., and Vice President of Medical Affairs and Strategy at WebMD. His research is published in leading peer-reviewed medical journals such as The American Journal of Medicine, The American Journal of Cardiology, Archives of Ophthalmology, Retina, and others. Dr. Sulkes holds a BA from Dartmouth College and a joint MD/MBA with research honors from Tufts University School of Medicine. He currently serves in voluntary roles on the Board of Directors of the Alliance for Continuing Medical Education where he is the incoming Vice President, and as a Mentor for the Blueprint Health accelerator program for healthcare IT start-ups. He is married with a son and resides in NYC.
Steve joins Medivo with over 20 years of financial management experience. He is skilled at directing and improving operational and financial processes with emerging businesses. Steve has successfully led the finance function of three private-equity backed technology companies from growth stage through sale by public company strategic acquirers. Steve gained considerable experience in healthcare as VP, Finance with Medsite, and with WebMD subsequent to WebMD’s acquisition of Medsite. Prior to Medivo, Steve was Corporate Controller of Oberon Media, a publisher of casual games and the leading multi-platform worldwide distributor of casual games. Steve also served as Corporate Controller of Fortent, a financial services software provider acquired by NICE Actimize. Prior to his corporate roles, Steve worked for 8 years in both the audit and mergers & acquisition practices with Deloitte, serving a variety of clients and industries. Steve is a licensed CPA and earned a BS in Accounting and Finance from Virginia Tech. Away from the office, Steve enjoys running and fitness and spending time with his family.
Anne has over 20 years of Executive Marketing leadership experience, which has included organizational and product design (from start-ups to publicly-traded companies), change management, resource allocation, branding, advertising, marketing, product development, market research, sales development, sales products, business analytic insights, pricing, packaging and positioning. Prior to Medivo, Anne was the SVP Consumer at WebMD and launched new audience segments and solutions, which fueled consumer traffic and revenue growth. Anne was instrumental in driving the trust consumers have in WebMD as a brand. In addition, Anne held some key leadership roles in other DTC businesses in the Financial industry and spent the early part of her career in various marketing roles at Medco. Anne’s career has spanned several constituents in health from a focus on the payer markets, to addressing value for the Life Sciences companies and to empowering consumers through the access of information to increasingly making decisions for themselves and their families. Her responsibilities in the consumer-facing health information businesses included solutions for web, mobile and print along with key brand strategies, plans, execution and delivery. In all these roles, her professional interests have been developing innovative solutions for multiple business segments and finding new approaches to the use of information to improve people’s lives.
JC Muyl has responsibility over Medivo’s Service Delivery, Data Production & Analytics & Customer Relationship Management. In his role, JC oversees the quality delivery of Health Information services to Medivo’s 3Ps – providers and patients and partners. In doing so, JC’s focus is in scaling Medivo’s Data Asset and Operational Capabilities. Prior to Medivo, JC was on the executive management team at C3i, a global IT Services provider for Pharmaceutical companies. Under JC’s tenure, the company grew from 30 to 1400 employees globally. JC’s contributions included the setup of C3i’s offshore operations in Hyderabad, India and Sofia, Bulgaria, the global ISO certification of the company as well as the launch and commercial ramp up of C3i’s Clinical Trial Services into a $20M Business Unit. Prior to joining C3i, JC was at American Express, where he led various CRM projects both domestically and internationally. JC graduated with a Master in Computer Sciences and a BA in Marketing from the SKEMA School of Business in Europe.
Mark has responsibility for building and managing Medivo’s clinical data management and analysis practice. He leads the development of new solution offerings and valuable insights that help clients drive better brand performance by leveraging Medivo’s unique data assets. Mark’s role includes strategic development of relevant and appropriate clinical data.
Mark’s career spans over 30 years of industry experience and he has built and managed high-performing analytics teams at manufacturers and suppliers. Prior to Medivo, Mark was the Chief Strategy Officer for ImpactRx, a Symphony Health Solutions Company. His experience at ImpactRx included SVP, Client Services Operations, where he was responsible for the development and delivery of advanced analytics, custom market research, and syndicated services. Prior to ImpactRx, Mark was with Merck for over 20 years. His last role was VP, Customer Insights, and COO, Comsort (a wholly-owned subsidiary). Mark received his BA in Mathematics and MA in Statistics both from Boston University.
Mark joined Medivo in mid-2013 as Senior Vice President, Clinical Data and Analytics Sales from Qforma, Inc. While with Qforma, he served in a number of senior sales leadership roles, most recently as Executive Vice President, Sales and Marketing.
Prior to Qforma, Mark was with PatientPoint™ (formerly Healthy Advice Networks™), where he served as Executive Vice President, Business Development. His primary responsibilities included product development and leading a business development team in the commercial launch of the innovative provider solution, PracticeWire™.
Earlier, Mark was a Partner, Life Science Practice, with Concord Management Group International™. With Concord, Mark lead Sales, Marketing and International Business Development.
Mark’s experience, prior to Concord, was in the area of Health Informatics (Pharmaceuticals), where he spent 8 years in positions of escalating sales leadership responsibility with IMSHealth™ and Symphony Health Solutions™ (formerly Wolters Kluwer Health™), where he was Vice President, Account Management.
Mark graduated from Miami University, Oxford, Ohio with a Bachelor of Science B.A., Finance.
From 2006 to 2011, Mark was at WebMD as Executive Director. In this capacity, Mark had management as well as sales responsibility for Professional (DTP) and Consumer (DTC) business units. Prior to WebMD, Mark spent four years at Medsite in New York, as VP of Sales where he was responsible for new business acquisition and helped establish Medsite as the eDetail industry leader. Medsite was acquired by WebMD in 2006. In addition, Mark spent 5 years with IDEAS International as VP of sales. IDEAS was a multi-national accounting software firm selling directly to the energy industry. Mark was located in New Jersey and Moscow where he drove sales and international expansion efforts. Mark attended Limerick University in Ireland.
Christina has over 15 years experience building people and organizational development programs that enable companies to meet business goals. In her leadership roles in the fields of health care, human resources, financial services, technology and marketing, Christina directed companies through mission and vision development, talent growth and retention, benefit plan design, compensation strategy, training and acquisition. Prior to Medivo, Christina pioneered the creation of performance development and training initiatives with an emphasis on sales at Sidney Frank Importing Company, Inc. She spent six years leading people development at Medsite, where she designed management and corporate university training programs that cultivated future leaders to inspire and manage the company’s growth and ultimate acquisition by WebMD. Christina also volunteers her time coaching leaders and running workshops on professional development for various non-profits in New York City. Christina has her master’s degree in organizational development from Robert J. Milano Graduate School in New York City and her bachelor’s degree from Goucher College in Baltimore.
For the last 10 years, Brett Shamosh has guided the creation, management and distribution of digital content and applications for media companies such as the NHL, Oxygen, CSTV (CBS College Sports) and Tango Media. At the age of 16, Brett was diagnosed with Ulcerative Colitis, a chronic digestive disease that impacts quality-of-life. During a flare of his disease in 2009, he developed a symptom tracking iPhone application to provide better data to his doctor and learn more about his symptoms, medications and diet. Upon recognizing the benefits, he became an interactive health evangelist to help fellow sufferers of chronic disease work closely with physicians to manage their health and wellness. In 2010, Brett started WellApps, an interactive health company that focused on mobile management of chronic diseases. Medivo acquired WellApps in 2012 and Brett joined the team as VP, Product Development, tasked with ensuring that all Medivo products provide meaningful value to providers and patients.
In the 4th grade Daniel was asked to step in into the hall because he was coaching fellow students on a similarity assignment he provided the class. Since then, Daniel’s passion for helping people has propelled him to be a creative developer of software and systems, and a team coach who excels at successfully delivering business value. This is his second foray building software for the healthcare field having previously designed software to help hospitals manage cases. He believes that healthcare is challenged by needless complexity and hopes his contribution will improve many people’s lives. Daniel founded QuietlyHelping in 2009 in order to have a direct hand in helping families with the struggles of debilitating disease. QuietlyHelping is an organization of compassion and empathy that brings ease, comfort, smiles, laughter, healing, and love to people battling cancer and other diseases. Spare time activities include cycling, occasional work as a musician, woodworking, photography, and reading books he never got around to in school. Unsurprisingly, Daniel is able to cook minute rice in just under thirty seconds.
John Alfano is an experienced business leader with a passion for making the world a better place. His experience spans over thirteen years running operations, program delivery, and product development, primarily in the healthcare marketing and technology space. As Senior Vice President of Community Development & Marketing for P\S\L Group America, John was responsible for the acquisition, retention and productivity of physicians and other healthcare professionals across all of P\S\L’s U.S. and international businesses. As Vice President of Product Development for Medsite Inc. (acquired by WebMD Health), John led the marketing and development of Medsite’s industry leading online detailing, medical education and market research solutions, and played a key role in building and growing one of the largest and most valuable physician databases in the industry. As Vice President and General Manager of Medsite Rewards™, the industry leader in honoraria fulfillment, John oversaw all operations, marketing, client service, customer support, materials management, and distribution, with full P&L management responsibility for the $20 million business unit. Prior to joining Medivo, John founded Global Renewable Energy Network (GReEN), the premier network for renewable energy professionals worldwide. John graduated from New York University, Leonard N. Stern School of Business with a B.S. in Marketing & International Business.
Rahim K. Hirji, RPh joined Medivo in 2012 as VP, Life Sciences Strategy following over a decade of commercial and medical affairs roles within various life sciences companies including Roche, Gilead Sciences, and Dendreon. Rahim brings broad commercial experience including market research, marketing, and medical education to Medivo which will serve to assist the company in maximizing the value of its offerings to life sciences clients. Prior to entering the biopharmaceutical industry, Rahim worked as a clinical pharmacist. Rahim holds degrees from the University of British Columbia and Cornell University.
Cathy Wong is an experienced business leader with a diverse background in the healthcare industry. At Medivo, she supports the Business Development team in their sales efforts, specifically in defining how Medivo can best support different pharmaceutical clients with our products and services. Previously, Cathy was a management consultant at Platform Advisors LLC (part of The CDM Group) and Booz & Co. where she focused exclusively on healthcare clients – pharma companies, payers and diagnostic lab companies. She has supported global healthcare clients in developing innovative growth strategies for their corporations as well as evaluating and implementing efficiency measures. She has also supported global pharmaceutical clients in driving growth for early-stage and in-line compounds as well as overall franchises in Oncology, Diabetes, Cardiology, Immunology and Biosimilars. In the early stages of her career, she also served as a Research & Development Scientist and Manufacturing Engineer at Merck & Co. In all of these roles, Cathy’s passion was in finding and developing innovative solutions to address pain points in the healthcare industry.
Cathy graduated with honors from the NYU Stern School of Business with a Masters of Business Administration and from Cornell University with a Bachelor of Science in Chemical Engineering.
Dr. Kurtzman has more than 25 years of experience as an entrepreneur, board member, financier and operator. As Managing Director of Healthcare at Safeguard Scientifics (NYSE:SFE), Dr. Kurtzman leverages his medical expertise to empower businesses to enhance their products, expand their services, and identify strategic partnership opportunities. Dr. Kurtzman has realized value for companies through a series of successful IPOs, M&A and turnaround transactions—most recently Shire’s acquisition of Safeguard’s partner company Advanced BioHealing for $750 million, in cash; and Eli Lilly’s acquisition of Safeguard’s partner company Avid Radiopharmaceuticals for $300 million, up front, with an additional $500 million payout dependent upon the achievement of future regulatory and commercial milestones. Dr. Kurtzman’s previous experiences include leadership roles at BioAdvance, Pluvita Corporation, Genovo, Avigen, and Gilead Sciences. Presently, Dr. Kurtzman is a lecturer in the Health Care Systems Department at the Wharton School at the University of Pennsylvania where he teaches entrepreneurship in life sciences. In addition, he is also a member of the board at Safeguard’s partner companies Alverix, Crescendo Bioscience, Good Start Genetics, Medivo and PixelOptics.
Dave Stack is an experienced leader in the life sciences industry with a distinguished track record of success. He is currently the President, CEO and Director of Pacira Pharmaceuticals, Inc., and a Founding Partner of Stack Pharmaceuticals, Inc., a commercialization, marketing and strategy firm serving emerging healthcare companies. In addition, he is a Managing Director at MPM Capital.
From September 2001 until August 2004 he was President, Chief Executive Officer and Director of The Medicines Company (NASDAQ:MDCO). Prior to The Medicines Company he was the CEO of Stack Pharmaceutical, Inc., where MDCO was one of the primary customers. From May 1995 to December 1999, he served as the President and General Manager of Innovex, Inc. responsible for the Americas. Innovex Inc. was a commercial solutions company offering a full range of marketing, sales and clinical development capabilities to pharmaceutical and biotechnology customers. From April 1993 to May 1995, he was the Vice President of Business Development and Marketing for Immunomedics, Inc (NASDAQ:IMMU) a biopharmaceutical company focusing on monoclonal antibodies in infectious disease and oncology. From May 1992 to March 1993, he was the Director of Business Development and Planning for Infectious Disease, Oncology and Virology for Roche Labs where he was the Therapeutic World Leader of Infectious Disease. Prior to that he held various positions with Roche Labs for approximately 12 years and was a retail and hospital pharmacist for three years after graduating from Albany College of Pharmacy, he also holds a BS in Biology from Siena College.
Mr. Stack was recognized as the Ernst and Young Entrepreneur of the Year in 2003 (New Jersey Healthcare). He is a Director of PepTx, Inc.
Joseph B. Volpe is an Investment Principal for Merck Global Health Innovation Group overseeing its evergreen Health Technology portion of the fund which represents half of the overall fund allocation. His deft technology, business development experience and technical engineering background are coupled with an in-depth understanding of emerging technologies in the health care industry.
With access to numerous leading life science, commercial channel, marketing and industry experts, Mr. Volpe continually identifies and develops transformative global health care opportunities that are adjacent to Merck’s core business of pharmaceuticals and vaccines. This venture mentality streamlined investment process provides expansion capital for existing businesses while identifying and reviewing thousands of new opportunities and/or investment targets.
Prior to joining Merck, Mr. Volpe’s 26-year career included a post serving within Johnson & Johnson’s Market Place Innovation team. He was responsible for technology innovations across Consumer, Medical Device and Diagnostics and Pharmaceutical sectors. Additionally, he has coordinated business development opportunities in the IT health care arena with concentration on applications in the evidence-based Medicine/Outcomes/e-marketing and sales platforms.
Dr. Sokolow has a unique career in healthcare, having been involved early in the development of healthcare informatics, and program development in demand and care management. His areas of expertise include value-based reimbursement, medical policy, medical management, high risk and condition management programs, provider relations and program implementation.
With Oxford, Dr. Sokolow was instrumental in the development of ETG based analyses of health care costs, as well as the pioneering design of case based contracting. At Empire Alan was responsible for refining transactional systems alerts, which led to systematic improvement in quality care. He has repeatedly lead teams in various engagements, which implemented high risk case management programs based on predictive models, resulting in significant cost savings and reduction in hospitalization. He is an expert in medical cost management.
Dr. Sokolow graduated from Pomona College and UCLA School of Medicine. He trained in Internal Medicine at the University of Utah, and at the University of Rochester. Board certified in Internal Medicine.
Vita Cassese has over 30 years of operations experience at Pfizer Inc, a $51 billion Fortune 30 company and focuses on investments in the healthcare and technology sectors. Most recently, she held the position of Vice President, Business Development, Strategy and Innovation. She previously served as CIO for Worldwide Pharmaceuticals, leading an organization of nearly 1,000 people in 44 countries and was a member of the Worldwide Pharmaceuticals Leadership Team which was responsible for long term business strategy. Vita has established industry-leading partnerships with Microsoft, Oracle, Cisco, Intel, and IBM. She was a key member of the Warner Lambert and Pharmacia acquisitions’ due diligence and integration teams. Previously, she served as Vice President of Business Technology and Market Research for the US Pharmaceuticals Group. In this role, she led many technology initiatives, one of which was honored with Management Science’s prestigious Prism Award.
Vita is a member of the Board of Trustees of the College of Mount St. Vincent. She is a guest lecturer at New York University’s Stern School of Business, MIT Sloan, and Boston University, and is a mentor at Columbia University. Vita holds a BA in Mathematics from the College of Mount Saint Vincent and an MBA from New York University’s Stern School of Business.
Lidia Fonseca most recently served as Chief Information Officer at Laboratory Corporation of America (LabCorp) from May 2008 to March 2013. Prior to LabCorp she served as EVP Global Operations and Technology at Synarc, Inc. from 2005 to early 2008. Prior to Synarc Lidia was at Philips Health Care from 1997 to 2005 in various roles including, the Global CIO of Philips Health Care and VP Supply Chain Management in the Nuclear Medicine Division. She holds an MBA and an MBI (Master Business Informatics) from the Rotterdam School of Management, Erasmus Graduate School of Business and a BA from the University of California at Berkeley. Lidia is married and has two children.
Ben Rooks is the founder of ST Advisors, a consultancy which works with healthcare companies and their financial sponsors on issues regarding strategy, financing and outcomes and exit planning. Rooks spent six years as an investment banker where he closed healthcare and medical technology transactions valued from $40 to $365 million.
Previously he spent close to a decade as a sell-side equity research analyst where he covered healthcare information stocks in addition to e-health, drug information and pharmacy benefit management. He has been a judge for the Microsoft Health Users Group (MS-HUG) Industry Solution Awards since its inception and was named a Zacks Investment Research All-Star Analyst.
Ben earned his MBA in healthcare management from The Wharton School of the University of Pennsylvania and his BA in psychology from Brandeis University.
Esther Dyson is actively involved in improving the world’s health, both as an investor and as the publisher on the Internet of her own genome and health records, as part of George Church’s Personal Genome Project. She believes fiercely in the power of information to affect people’s behavior and to improve the quality of health care. She brings to her work insights from economics, information technology, management practice and practical psychology.
As an investor, she was an early investor in and board member of Medscape, now part of WebMD. She was also an investor in Medstory, now part of Microsoft. Currently, she is an investor in and sits on the board of 23andMe. She is also an investor in Contagion Health, HealthEngage, HealthTap, HealthVillage, Keas, Medicalgorithmics, Organized Wisdom, PatientsLikeMe, PatientsKnowBest, Resilient, Tocagen and Voxiva (creator of Text4baby). She has written two monographs on electronic records and health information liquidity, and ran the 2005 Personal Health Information workshop co-sponsored by New York’s New School University.
A 1995 “pioneer” of the medical internet, Dr. Lundberg was born in Florida, grew up in rural southern Alabama and holds earned and honorary degrees from North Park College, Baylor University, the University of Alabama (Birmingham and Tuscaloosa), the State University of New York, Syracuse, Thomas Jefferson University and the Medical College of Ohio. He completed a clinical internship in Hawaii and a pathology residency in San Antonio. He served 11 years in the US Army during the Vietnam War Era in San Francisco and El Paso. Dr. Lundberg was Professor of Pathology and Associate Director of Laboratories at the Los Angeles County/USC Medical Center for 10 years, and for five years was Professor and Chair of Pathology at the University of California, Davis.
Dr. Lundberg has worked in tropical medicine in Central America and Forensic Medicine in New York, Sweden and England. He is past President of the American Society of Clinical Pathologists. From 1982 to 1999, Dr. Lundberg was at the American Medical Association as Editor in Chief, Scientific Information and Multimedia with editorial responsibility for its 39 medical journals, American Medical News, and various Internet products, and the Editor of JAMA.
In 1999 Dr. Lundberg became Editor in Chief of Medscape, and the founding Editor in Chief of both Medscape General Medicine and CBS HealthWatch.com. In 2002, Dr. Lundberg was Special Healthcare Advisor to the Chairman and CEO of WebMD for 2 years. Later, he served as the Editor in Chief of The Medscape Journal of Medicine, the original open access general medical journal, and beginning in 2006, Editor in Chief of eMedicine from WebMD, the original open access comprehensive medical textbook. A frequent lecturer, radio, television and webcasting guest and host, and a member of the Institute of Medicine of the National Academy of Sciences, Dr. Lundberg was a Professor at Harvard from 1993 to 2008. Dr Lundberg left WebMD in 2009 and is now Editor in Chief, Cancer Commons; Editor at Large, MedPage Today, a Consulting Professor at Stanford and is President and Board Chair of The Lundberg Institute. In 2000, the Industry Standard dubbed Dr. Lundberg “Online Health Care’s Medicine Man”.
Dr. Marshall has over ten years experience in the health care technology solutions field, having made significant advancement in personal health records, electronic health records, personalized decision support and personalized genomic solutions. He created and implemented the Press Ganey Improvement Portal, a comprehensive performance management portal for health systems, including large hospitals and medical practices. In 2007, he was honored by Frost & Sullivan with the Market Leadership Award for his Personal Health Records (PHR) Solution that enables consumers to gather, store, manage and share their essential health data from across multiple providers and data sources.
Dr. Marshall attended medical school at Indiana University and received his Masters in Public Health from Oregon Health and Science University. He currently serves as Senior Vice President of Clinical Products for Press Ganey, and is a member of Markle Foundations’ Connecting for Health Steering Group and the Commission for the Certification of Health Information Technology (CCHIT).
Dr. Roshini Raj is board certified in Gastroenterology and Internal Medicine with a medical degree from New York University School of Medicine and an undergraduate degree from Harvard College. Currently, Dr. Raj is an attending physician at NYU Medical Center/Tisch Hospital in New York City, where she was the first female gastroenterologist to join the faculty. She also serves as an Assistant Professor of Medicine at the NYU School of Medicine. Dr. Raj has a special interest in women’s health and cancer screening and has published several research articles on colon cancer screening.
Dr. Raj is a Today Show medical contributor and Medical Editor of Health Magazine. In August 2010, her first book, What the Yuck?! The Freaky & Fabulous Truth About Your Body, debuted. Dr. Raj has discussed a wide variety of health topics on a range of network and cable shows, including NBC’s Today Show; ABC’s Good Morning America and World News Tonight; CNN’s American Morning, Nancy Grace, and Larry King Live; The Discovery Health Channel; The Tyra Banks Show; and The Dr.Oz show, among others.
Dr. Raj has been quoted in several publications, including The New York Times, The Wall Street Journal, Cosmopolitan, Men’s Health, Women’s Health and Fitness on the state of healthcare and health news of the day.
Dr. Raj resides in New York City with her husband and two children.
David Nash is the Founding Dean at the Jefferson School of Population Health (JSPH) of Thomas Jefferson University in Philadelphia, Pennsylvania. JSPH provides innovative graduate degree programs in Public Health, Healthcare Quality and Safety, Health Policy, Chronic Care Management and Applied Health Economics.
Dr. Nash is a board certified internist who is internationally recognized for his work in outcomes management, medical staff development and quality-of-care improvement.
Through publications, public appearances, his blog and an online column on MedPage Today, Dr. Nash reaches more than 100,000 persons every month.
Dr. Nash is a consultant to organizations in both the public and private sectors. He has chaired the Technical Advisory Group of the Pennsylvania Health Care Cost Containment Council for a decade where he helped to pioneer public reporting of outcomes. In early 2011, he was named to the Board of Directors for Endo Pharmaceuticals. In December 2009, he joined the Board of Directors for Humana Inc. He also serves on the Board of Main Line Health – a four hospital system in suburban Philadelphia, PA, where he chairs the Board Quality Committee.
George Bakris, MD, is a professor at The University of Chicago Medicine. He also serves as the director of the medical school’s Medicine Hypertension Center and is a designated hypertension specialist.
A past president of The American Society of Hypertension (ASH), the largest organization of hypertension researchers and health care providers in the United States, Dr. Bakris specializes in the diagnosis and reduction of high blood pressure, particularly in complicated and refractory cases. He is also skilled in the treatment of kidney disease, with special expertise in diabetes-related kidney disease.
In his research, Dr. Bakris explores why the rate of kidney disease is significantly higher in the black population than it is in other ethnic groups. Dr. Bakris, who started practicing in 1988, also evaluates specific markers of kidney disease progression and heightened cardiovascular risk, as well as how changes in the artery (central pressure) affect the heart and kidney.
Most recently, Dr. Bakris has served as the national principal investigator on two clinical trials: one trial involves renal denervation as a way to lower blood pressure in people with resistant hypertension; the other investigates a new polymer designed to lower potassium among those with kidney disease and persistently high potassium values.
David A. Johnson is a professor of medicine and the chief of gastroenterology at the Eastern Virginia Medical School in Norfolk, Va. Dr. Johnson, FACG, FACP has received board certification for Internal Medicine and Gastroenterology, and is a past president of the American College of Gastroenterology (ACG).
He continues working on the executive committee for the ACG’s board of trustees and the ACG Research Institute, and has been extensively involved in committees of the national GI societies.
Widely published in peer-reviewed journals focusing on internal medicine and gastroenterology, Dr. Johnson has contributed to more than 350 articles, chapters and abstracts. His publication activities include serving as the past co-editor of Reviews in Gastroenterological Disorders and as the current GI section editor for Medscape Gastroenterology and Journal Watch Gastroenterology (New England Journal of Medicine).
Dr. Johnson is on numerous editorial boards and is a reviewer for 18 medical journals, including all of the GI journals, as well as a number of prestigious internal medicine journals (Annals of Internal Medicine, Archives of Internal Medicine, and American Journal of Medicine, among others).
William R. Lumry, MD, is a clinical professor of Internal Medicine in the Allergy Division at the University of Texas Southwestern Medical School, Dallas, and teaches at Parkland Memorial and Presbyterian Hospitals in Dallas.
Dr. Lumry is the medical director of AARA Research Center and participates actively in clinical research projects involving new treatments for asthma and allergic diseases and hereditary angioedema. He has lectured to local, national and international conferences and published many articles and abstracts in prominent medical journals on these subjects.
Dr. Lumry is a Fellow of the American College of Physicians and the American Academy and College of Allergy, Asthma and Immunology. He also is a board certified Internist and Allergist. His is in private practice in Dallas, Texas treating adults and children with allergic diseases and asthma.
He received his medical degree from the University of Texas Medical Branch at Galveston, completed his internal medicine training at Washington University in St. Louis and received his clinical and research fellowship in allergy and immunology from Scripps Clinic in La Jolla, Calif.
Nancy S. Reau, MD, is an associate professor at the University of Chicago’s School of Medicine. She specializes in the diagnosis and management of liver diseases, and is widely regarded as an expert in hepatitis B, hepatitis C, non-alcoholic liver disease and liver transplant procedures.
Dr. Reau is a member of the American Association for the Study of Liver Diseases (AASLD) practice guideline committee, the American College of Gastroenterology (ACG) women’s committee and is the current vice president of the board of directors of the American Liver Foundation (ALF), Illinois Chapter.
A graduate of the medical school at Ohio State University, Dr. Reau is board certified in Gastroenterology, Internal Medicine and Transplant Hepatology.
David T. Rubin, MD, is a professor of medicine and co-director of the Inflammatory Bowel Disease Center at the University of Chicago Medical Center. He also is the Associate Section Chief for Educational Programs.
In 2011, Dr. Rubin was named to a list of the nation’s top gastroenterologists.
Dr. Rubin specializes in the treatment and assessment of digestive diseases. His clinical expertise includes inflammatory bowel diseases (Crohn’s disease and ulcerative colitis) and high-risk cancer syndromes.
In his clinical research, Dr. Rubin performs work related to outcomes in inflammatory bowel diseases, with particular interest in prevention of cancer associated with these diseases. He also has a strong interested in new therapies for inflammatory bowel diseases, better screening tools for colorectal cancer, and the genetics of inflammatory bowel diseases.
Dr. Rubin, who began practicing in 1994, is board certified in Gastroenterology (University of Chicago).
His work in caring for Crohn’s disease patients at the University of Chicago has been featured in news stories, including a report on how one of his patients completed a week-long, 475-mile bike ride across Iowa shortly after seeking care from Dr. Rubin, and another story highlighted his efforts in treating a father and daughter who were diagnosed with Crohn’s disease.